I have over fifteen years of experience in software requirements analysis, algorithm design, and Mass Spec data analysis. I have been driving the development and commercialization of the MS line of products – software solutions for glycomics, lipidomics, metabolomics, biopharma characterization: released glycan analysis. Some recent works I participated include development of the following workflows: 1. “Lipidomics using TIMS and PASEF MS” in collaboration with Bruker, and Max-Planck Institute of Biochemistry, Germany. 2. “Lipid Profiling of Complex Biological Mixtures by UHPLC-SONAR MS" in collaboration with Waters Corporation, UK. 3. "Identification and Quantitation of N-Glycans from Infliximab using UHPLC-Orbitrap-MS Analysis" in collaboration with Thermo & NIBRT.